Search results for the GEO ID: GSE6381
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM147131
GPL96
Stage2, End-ischemia, Replicate1 Heart End-ischemia sample was taken at 50 minutes of cardiac arrest. All myocardial samples were taken from the RVOT through the tricuspid valve. All the chips were controlled for presence of any defect before scanning.
GSM147133
GPL96
Stage2, End-ischemia, Replicate2 Heart End-ischemia sample was taken at 50 minutes of cardiac arrest. All myocardial samples were taken from the RVOT through the tricuspid valve. All the chips were controlled for presence of any defect before scanning.
GSM147134
GPL96
Stage2, End-ischemia, Replicate3 Heart End-ischemia sample was taken at 50 minutes of cardiac arrest. All myocardial samples were taken from the RVOT through the tricuspid valve. All the chips were controlled for presence of any defect before scanning.
GSM147135
GPL96
Stage2, End-ischemia, Replicate4 Heart End-ischemia sample was taken at 50 minutes of cardiac arrest. All myocardial samples were taken from the RVOT through the tricuspid valve. All the chips were controlled for presence of any defect before scanning.
GSM147136
GPL96
Stage1, Immediately post-cardioplegic arrest, Replicate1 Heart Sample was taken immediately after cardiac arrest following administration of standard hyperkalemic, cold blood cardioplegia (30ml/kg), which was repeated (20ml/kg) every 20 minutes All myocardial samples were taken from the RVOT through the tricuspid valve All the chips were controlled for presence of any defect before scanning.
GSM147137
GPL96
Stage1, Immediately post-cardioplegic arrest, Replicate2 Heart Sample was taken immediately after cardiac arrest following administration of standard hyperkalemic, cold blood cardioplegia (30ml/kg), which was repeated (20ml/kg) every 20 minutes All myocardial samples were taken from the RVOT through the tricuspid valve All the chips were controlled for presence of any defect before scanning.
GSM147138
GPL96
Stage1, Immediately post-cardioplegic arrest, Replicate3 Heart Sample was taken immediately after cardiac arrest following administration of standard hyperkalemic, cold blood cardioplegia (30ml/kg), which was repeated (20ml/kg) every 20 minutes All myocardial samples were taken from the RVOT through the tricuspid valve All the chips were controlled for presence of any defect before scanning.
GSM147139
GPL96
Stage1, Immediately post-cardioplegic arrest, Replicate4 Heart Sample was taken immediately after cardiac arrest following administration of standard hyperkalemic, cold blood cardioplegia (30ml/kg), which was repeated (20ml/kg) every 20 minutes All myocardial samples were taken from the RVOT through the tricuspid valve All the chips were controlled for presence of any defect before scanning.
GSM148145
GPL96
Stage 3, after 5 min. Reperfusion, Replicate1 Heart Sample was taken at 5 minutes after reperfusion prior to right atrial closure. All myocardial samples were taken from the RVOT through the tricuspid valve. All the chips were controlled for presence of any defect before scanning
GSM148146
GPL96
Stage 3, after 5 min. Reperfusion, Replicate2 Heart Sample was taken at 5 minutes after reperfusion prior to right atrial closure. All myocardial samples were taken from the RVOT through the tricuspid valve. All the chips were controlled for presence of any defect before scanning
GSM148147
GPL96
Stage 3, after 5 min. Reperfusion, Replicate3 Heart Sample was taken at 5 minutes after reperfusion prior to right atrial closure. All myocardial samples were taken from the RVOT through the tricuspid valve. All the chips were controlled for presence of any defect before scanning
GSM148149
GPL96
Stage 3, after 5 min. Reperfusion, Replicate4 Heart Sample was taken at 5 minutes after reperfusion prior to right atrial closure. All myocardial samples were taken from the RVOT through the tricuspid valve. All the chips were controlled for presence of any defect before scanning
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes